We are live on ! Find out more
DALS

DA32 Life Science Tech Acquisition Corp

Delisted

DALS was delisted on the 28th of July, 2023.

44 hedge funds and large institutions have $150M invested in DA32 Life Science Tech Acquisition Corp in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 7

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

22% more funds holding

Funds holding: 36 → 44 (+8)

4.85% less ownership

Funds ownership: 79.74% → 74.89% (-4.9%)

20% less capital inflows, than outflows

Capital inflows: $41.7M | Capital outflows: $52.1M

Holders
44
Holders Change
+8
Holders Change %
+22.22%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
8
Reduced
5
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

DALS Hedge Fund Activity: Q1 2022 in Review

44 of the 6,366 institutional investors tracked by Wall St. Rank reported a position in DA32 Life Science Tech Acquisition Corp (DALS) for Q1 2022, worth a combined $150M — down 6.9% from $162M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new DALS positions and 7 closed out — a net gain of 8 holders — while 8 added to existing stakes and 5 trimmed.

The largest buyer was Saba Capital Management, opening a new position worth an estimated $10.8M. The largest seller was Wellington Management Group, exiting entirely with an estimated $28.1M sold.

  • 44 institutional investors held DA32 Life Science Tech Acquisition Corp (DALS) as of Q1 2022, up from 36 in Q4 2021.
  • Funds reported $150M of DA32 Life Science Tech Acquisition Corp stock for Q1 2022, down 6.9% quarter-over-quarter.
  • 15 funds opened new DA32 Life Science Tech Acquisition Corp positions in Q1 2022 and 7 closed out, a net change of +8 holders.
  • The largest DA32 Life Science Tech Acquisition Corp buyer in Q1 2022 was Saba Capital Management, an estimated $10.8M added.
  • The largest DA32 Life Science Tech Acquisition Corp seller in Q1 2022 was Wellington Management Group, an estimated $28.1M sold.

Based on aggregated 13F filings for Q1 2022.